City page
Oslo biotech and pharma directory
Oslo is a life-science cluster in Norway with 9 verified companies in this directory, spanning Therapeutics, Diagnostics, Cluster. Its anchor companies include Oncoinvent ASA, Photocure, Thor Medical ASA, Zelluna ASA. Every profile is hand-reviewed against leadership sources, a verified physical address, and regulatory certifications.
Where does this city read strongest?
Therapeutics (5), Diagnostics (2), and Cluster (1). Most visible records: Age Labs AS, Calluna Pharma AS, and ClexBio AS.
Which standards and public evidence are already visible?
GMP (1). Latest review: 24 April 2026. Review cycle: April 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Oslo.
By category
Oslo by category
Jump into a category page filtered to this country only.
Full list
Oslo biotech and pharma directory
9 city records currently match the active filter.
Current review cycle
Age Labs AS
OsloNorwayDiagnostics
Oslo molecular diagnostics startup developing DNA methylation and epigenetic biomarker tests for age-related diseases, with a lead candidate targeting early-stage rheumatoid arthritis diagnosis.
- Lead
- Andre LovestamChief Executive Officer
- Scale
- Molecular diagnostics development
Current review cycle
Calluna Pharma AS
OsloNorwayTherapeutics
Oslo clinical-stage antibody biotech targeting fibrosis and inflammation through the first-in-class anti-S100A4/S100A9 antibody CAL101, with Phase 1 completed in October 2024 and backing from Forbion.
- Lead
- Mark GaffneyChief Executive Officer
- Scale
- Clinical-stage antibody development
Current review cycle
ClexBio AS
OsloNorwayBiotech
Pre-clinical regenerative-medicine startup building vascularized, cell-synthesized extracellular-matrix implants via the CLEX hydrogel scaffold and VivoSet platform, with early applications in Type-1 diabetes, liver, and heart disease.
- Lead
- Armend G. HatiChief Executive Officer and Co-Founder
- Scale
- Pre-clinical tissue engineering
Current review cycle
Oncoinvent ASA
OsloNorwayTherapeutics
Oslo-listed clinical-stage radiopharmaceutical developer running Phase 2 trials of Radspherin, a radium-224 alpha-emitter microsphere for ovarian peritoneal metastases, following the October 2025 merger with BerGenBio.
- Lead
- Oystein SougChief Executive Officer
- Scale
- GMP clinical-trial-material production
Current review cycle
Oslo Cancer Cluster
OsloNorwayCluster
Norway's flagship oncology innovation cluster and Norwegian Centre of Expertise, co-locating approximately 100 cancer-focused biotech SMEs, Oslo University Hospital, and the Cancer Registry of Norway at the Ullern Innovation Park.
- Lead
- Ketil WiderbergGeneral Manager
- Scale
- Cluster coordination and incubator operations
Current review cycle
Thor Medical ASA
OsloNorwayTherapeutics
Oslo-listed radiopharmaceutical developer (formerly Nordic Nanovector) focused on alpha-emitter production (radium-224 and Pb-212) for next-generation cancer therapy, with pilot radionuclide production at Heroya.
- Lead
- Alf BjorsethChief Executive Officer
- Scale
- Pilot radiopharmaceutical production
Current review cycle
Zelluna ASA
OsloNorwayTherapeutics
Euronext Oslo-listed cell therapy company (formed February 2025 from the Ultimovacs and Zelluna Immunotherapy business combination) developing off-the-shelf TCR-NK cell therapies for solid tumors, with a lead MAGE-A4 program advancing toward IND.
- Lead
- Namir HassanChief Executive Officer
- Scale
- Clinical-stage cell therapy development
Current review cycle
Photocure
OsloNorwayDiagnostics
Oslo bladder-cancer diagnostics headquarters coordinating blue-light cystoscopy commercialization, clinical evidence, and market development.
- Lead
- Dan SchneiderPresident and Chief Executive Officer
- Scale
- Commercial diagnostics operations
Current review cycle
Nykode Therapeutics
OsloNorwayTherapeutics
Oslo clinical-stage immunotherapy company running its DNA-based platform, oncology programs, and partner-facing operations from the Oslo Science Park headquarters.
- Lead
- Michael EngsigChief Executive Officer
- Scale
- Drug Development
FAQ
Frequently asked questions
- How many biotech companies are in Oslo?
- Oslo hosts 9 verified life-science companies in this directory — spanning Therapeutics, Diagnostics, Cluster. The exact count appears in the page header above and updates with each directory refresh.
- What are the leading biotech companies in Oslo?
- Oslo's anchor companies include Oncoinvent ASA, Photocure, Thor Medical ASA, Zelluna ASA. Each is hand-reviewed against primary leadership sources, a verified physical address, and regulatory certifications.
Related briefs
Briefs that mention Oslo
European mRNA & Immunotherapy Supply Chain 2026
Where the European mRNA, vaccine, and immunotherapy supply chain actually sits in 2026 — BioNTech, CureVac, IDT Biologika, AGC Biologics, BioSpring, Bachem, plus the Nordic vaccine layer — and how the pieces fit.
Open briefViral Vector CDMO Europe 2026: AAV, Adenovirus, Lentivirus
Where to manufacture viral vectors in Europe in 2026 — FinVector, Kuopio Center for Gene and Cell Therapy, 3PBIOVIAN, Fuse Vectors, IDT Biologika — and how the European viral vector CDMO layer is structured.
Open briefNordic Biotech Landscape 2026: Denmark, Sweden, Finland, Norway
A practical map of the Nordic biotech and pharma landscape in 2026 — 124 operators across Denmark, Sweden, Finland, and Norway, anchored by Novo Nordisk, Genmab, Lundbeck, AstraZeneca Gothenburg, Bavarian Nordic, Orion, and a dense Medicon Valley + Karolinska cluster layer.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.